Average Co-Inventor Count = 4.15
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Patent Gmbh (23 from 2,943 patents)
2. Merck Patent Gesellschaft MIT Beschrankter Haftung (4 from 1,248 patents)
3. Solvay Pharmaceuticals, Gmbh (2 from 75 patents)
4. Other (1 from 832,843 patents)
5. Merck Patent Gesellschaft (1 from 121 patents)
6. Solvay Pharmaceuticals, B.v. (1 from 67 patents)
7. Ryvu Therapeutics S.a. (3 patents)
32 patents:
1. 12378225 - Process for manufacturing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide
2. 12351570 - Disubstituted alkyne derivatives
3. 10093623 - Cyclic amides as MetAP-2 inhibitors
4. 10005756 - Pyrrolidinone derivatives as MetAP-2 inhibitors
5. 9249140 - Bicyclic heteroaromatic compounds
6. 9238651 - 1-H-pyrrolo[2,3-b]pyridine derivatives
7. 9199962 - Substituted azaheterocycles for the treatment of cancer
8. 8993564 - 7-azaindole derivatives suitable for treatment of cancers
9. 8906916 - Pyrimidine derivatives as FAK inhibitors
10. 8895575 - 1 H-pyrrolo[2,3-b]pyridine derivatives
11. 8895535 - Pyrrolidinones as MetAP-2 inhibitors
12. 8859581 - Azaheterocyclic compounds as kinase inhibitors
13. 8846694 - Pyrrolidone derivatives for use as MetAP-2 inhibitors
14. 8815870 - 4-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereof
15. 8703961 - Thiazole derivatives for the treatment of diseases such as cancer